Literature DB >> 32471152

Cytokines and Chemokines in Chikungunya Virus Infection: Protection or Induction of Pathology.

Chintana Chirathaworn1,2, Jira Chansaenroj2, Yong Poovorawan2.   

Abstract

Chikungunya virus (CHIKV) infection has been commonly detected in tropical countries. The clinical manifestations of CHIKV infection are similar to those of rheumatoid arthritis. Outbreaks of CHIKV infection in Thailand have been reported, and the inductions of various cytokines and chemokines in CHIKV patients during those outbreaks have been shown. Although immune responses in CHIKV infection have been increasingly reported, the mechanisms associated with pathology induction are still not clearly understood. This review focuses on cytokine and chemokine production in CHIKV infection, in association with the severity of joint inflammation. Several cytokines and chemokines involved in the induction or regulation of inflammatory responses were shown to associate with the severe and persistent symptoms in CHIKV infection. Further studies on the difference in immune responses observed in an autoimmune disease, rheumatoid arthritis, infectious disease, and CHIKV infection, would provide additional insights useful for proper CHIKV therapy, especially in patients with severe joint pains.

Entities:  

Keywords:  chikungunya; cytokine; immune response

Year:  2020        PMID: 32471152     DOI: 10.3390/pathogens9060415

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  6 in total

1.  Role of cytokines, chemokines, C3a, and mannose-binding lectin in the evolution of the chikungunya infection.

Authors:  Berta N Restrepo; Katerine Marín; Paola Romero; Margarita Arboleda; Ana L Muñoz; Irene Bosch; Heriberto Vásquez-Serna; Orlando A Torres
Journal:  Am J Clin Exp Immunol       Date:  2022-06-15

2.  EGR1 Upregulation during Encephalitic Viral Infections Contributes to Inflammation and Cell Death.

Authors:  Caitlin W Lehman; Amy Smith; Jamie Kelly; Jonathan L Jacobs; Jonathan D Dinman; Kylene Kehn-Hall
Journal:  Viruses       Date:  2022-06-02       Impact factor: 5.818

3.  Telmisartan Restricts Chikungunya Virus Infection In Vitro and In Vivo through the AT1/PPAR-γ/MAPKs Pathways.

Authors:  Prabhudutta Mamidi; Soumyajit Ghosh; Saikat De; Supriya Suman Keshry; Chandan Mahish; Sweta Smita Pani; Eshna Laha; Amrita Ray; Ankita Datey; Sanchari Chatterjee; Sharad Singh; Tathagata Mukherjee; Somlata Khamaru; Subhasis Chattopadhyay; Bharat Bhusan Subudhi; Soma Chattopadhyay
Journal:  Antimicrob Agents Chemother       Date:  2021-11-08       Impact factor: 5.938

4.  Increased Indoleamine 2,3-Dioxygenase 1 (IDO-1) Activity and Inflammatory Responses during Chikungunya Virus Infection.

Authors:  Thiara Manuele Alves de Souza; Caroline Fernandes-Santos; Jéssica Araújo da Paixão de Oliveira; Larissa Cristina Teixeira Tomé; Victor Edgar Fiestas-Solórzano; Priscila Conrado Guerra Nunes; Gabriel Macedo Costa Guimaraes; Juan Camilo Sánchez-Arcila; Iury Amâncio Paiva; Luís Jose de Souza; Paulo Vieira Damasco; Válber da Silva Frutuoso; Manoela Heringer; Luzia Maria de Oliveira-Pinto; Roberta Olmo Pinheiro; Flavia Barreto Dos Santos; Elzinandes Leal de Azeredo
Journal:  Pathogens       Date:  2022-04-07

5.  Pro-Inflammatory Profile of Children Exposed to Maternal Chikungunya Virus Infection during the Intrauterine Period: A One-Year Follow-Up Study.

Authors:  Renan Faustino; Fabiana Rabe Carvalho; Thalia Medeiros; Débora Familiar-Macedo; Renata Artimos de Oliveira Vianna; Paulo Emílio Côrrea Leite; Isabela Resende Pereira; Claudete Aparecida Araújo Cardoso; Elzinandes Leal De Azeredo; Andrea Alice Silva
Journal:  Viruses       Date:  2022-08-26       Impact factor: 5.818

6.  Mst1 promotes mitochondrial dysfunction and apoptosis in oxidative stress-induced rheumatoid arthritis synoviocytes.

Authors:  Yingjie Wang; Qi Yang; Songpo Shen; Linjie Zhang; Yongbo Xiang; Xisheng Weng
Journal:  Aging (Albany NY)       Date:  2020-07-21       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.